NCT02633787View on ClinicalTrials.gov

Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier

PHASE4CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

March 31, 2016

Conditions

MeningitisMeningococcal MeningitisMeningococcal Infections

Interventions

BIOLOGICAL

Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

No vaccine will be administered in this trial

Trial Locations (4)

40004

Bardstown

49120

Niles

84041

Layton

01801

Woburn

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT02633787 - Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier | Biotech Hunter | Biotech Hunter